Tumor Growth Rate (TGR) as an Indicator of Antitumor Activity With Lanreotide Autogel/Depot (LAN) Versus Placebo (Pbo) in Intestinal/Pancreatic NET: Post Hoc Analysis of CLARINET Data


Clinical Advances in Hematology and Oncology H&o 14(5 Suppl. 7): 6-7

2016


ISSN/ISBN: 1543-0790
PMID: 27168103
Document Number: 687297

Document emailed within 1 workday
Secure & encrypted payments